EVALUATION OF LIVER FIBROTIC FORMATION IN PATIENTS WITH CHRONIC PANCREATITIS USING NON-INVASIVE AST/ALT INDEX, APRI INDEX, FIB4 SCORE
Introduction: Increasing world population, population migration, changes in alcohol use, tobacco use, diet, increasing obesity and metabolic syndrome among the younger generation adds to the epidemiology of chronic pancreatitis. Metabolic-associated fatty liver disease (МAFLD) is one of the chronic metabolic diseases that most often develops against a background of type 2 diabetes mellitus (DM), obesity and arterial hypertension. The development of MAJBP in patients with chronic pancreatitis is provoked by unbalanced diet, stress, alcohol consumption and smoking, as well as the presence of overweight or obesity in the patient and other environmental and lifestyle factors contribute to the progression of МAFLD.
Objective: To study the diagnostic value of non-invasive indices AST/ALT, APRI index (Aminotransferase to platelet ratio index) and Fibrosis-4 Score (FIB-4 Score) Index in patients with chronic pancreatitis for assessment of liver fibrosis.
Materials and methods: Our study was a single case retrospective cross-sectional study. It included male and female patients aged 18 to 75 years with a confirmed diagnosis of chronic pancreatitis, who received inpatient treatment in the Department of Gastroenterology of the University Hospital of ‘Semey Medical University’ during the period 01.01.2021 to 31.12.2023. Patients with malignant neoplasms, pregnancy, lactation were excluded from the study. Non-invasive indices - AST/ALT, APRI index (Aminotransferase to platelet ratio index) and Fibrosis-4 Score (FIB-4 Score) Index were used to assess fibrosis formation in the liver.
Results: We selected 331 case histories of patients with chronic pancreatitis, including 218 women and 113 men. When studying the mean values of AST/ALT ratio, we found a difference by sex (p=0.001), BMI (p=0.04). Higher mean AST/ALT values were found more often in men compared to women. High AST/ALT values were more frequent in overweight and obese patients. The difference in mean APRI index values was found only in BMI groups (p=0.03). High APRI index values were also more common in overweight and obesity. When we studied the distribution of risk factors for liver fibrosis according to AST/ALT ratio, the chance of developing liver fibrosis was 1.82 times higher in men compared to women (p=0.001). Also according to AST/ALT ratio data the chance of liver fibrosis development was increased in case of overweight and obesity (p=0.04). Whereas, the mean values of FIB-4 Score differed by gender (p=0.02) and in patients with and without type 2 DM (p=0.006).
Conclusions: Thus, the application in practice of diagnostic non-invasive indices AST/ALT, APRI index, FIB-4 Score in patients with chronic pancreatitis may help for early diagnosis and evaluation of liver fibrosis.
Keywords: pancreatitis, steatosis, liver fibrosis, AST/АLТ, APRI index, FIB-4 Score.
Aizhan Т. Shakhanova1, http://orcid.org/0000-0001-8214-8575
Zauresh K. Zhumadilova1, https://orcid.org/0000-0001-6211-6154
Alida Sh. Kaskabaeva1, http://orcid.org/0000-0002-5184-214X
Tungyshkhan E. Shakhanov1, http://orcid.org/0000-0002-8698-7541
Zhanna E. Muzdubaeva1, http://orcid.org/0000-0002-9058-1878
Ainur K. Uzbekanova2,
Asel Zh. Kozybaeva2,
Yasmin E. Baybakirova1, http://orcid.org/0009-0002-1169-3706
Ayazhan N. Akhan1, http://orcid.org/0009-0007-0284-963X
Есина М.В. и др. Распространенность неалкогольной жировой болезни печени среди пациентов с сердечно-сосудистыми заболеваниями. Материалы XXII научно-практической конференции молодых ученых, аспирантов и студентов Национального исследовательского Мордовского государственного университета им. Н.П. Огарёва. 2019. C. 294–297.
2. Раимкулова Н.Р., Мамадалиева Н.И., Обидова Д.Д. Распространенность неалкогольной жировой болезни печени и желчекаменной болезни. International Journal of Discourse on Innovation, Integration and Education. 2020. № 5 (1). C. 58–60.
3. Araújo A.R. et al. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future. Liver International. 2018. № November. 2017 (38). P. 47–51.
4. Beyer G. et all. Chronic pancreatitis. Lancet (London, England). 2020. № 10249 (396). P. 499–512.
5. Das K. et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology. 2010. № 5 (51). P. 1593–1602.
6. Hou S. et all. Fatty liver disease is associated with the severity of acute pancreatitis:A systematic review and meta-analysis. International journal of surgery (London, England). 2019. (65). P. 147–153.
7. Kabir M.A. et all. Prevalence of Non-Alcoholic Fatty Liver Disease and Its Biochemical Predictors in Patients with Type-2 Diabetes Mellitus. Mymensingh medical journal : MMJ. 2018. № 2 (27). P. 237–244.
8. Kumar R. et all. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease? Indian journal of endocrinology and metabolism. 2013. № 4 (17). P. 665–71.
9. McPherson S. et al. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis. The American journal of gastroenterology. 2017. № 5 (112). P. 740–751.
10. Petrov M.S. Editorial: abdominal fat: a key player in metabolic acute pancreatitis. The American journal of gastroenterology. 2013. № 1 (108). P. 140–2.
11. Succurro E. et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity. 2008. № 8 (16). P. 1881–1886.
12. Wu D. et al. Nonalcoholic Fatty Liver Disease Aggravated the Severity of Acute Pancreatitis in Patients. BioMed research international. 2019. (2019). P. 9583790.
13. Xiao A.Y. et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. The lancet. Gastroenterology & hepatology. 2016. № 1 (1). P. 45–55.
Number of Views: 60
Bibliography link
Shakhanova A.T., Zhumadilova Z.K., Kaskabaeva A.Sh., Shakhanov T.E., Muzdubaeva Zh.E., Uzbekanova A.K., Kozybaeva A.Zh., Baybakirova Y.E., Akhan A.N. Evaluation of liver fibrotic formation in patients with chronic pancreatitis using non-invasive AST/ALT index, APRI index, FIB4 Score // Nauka i Zdravookhranenie [Science & Healthcare]. 2024. Vol.26 (3), pp. 7-15. doi 10.34689/SH.2024.26.3.001Related publications:
VALIDATION OF THE KAZAKH VERSION OF THE DEPRESSION ANXIETY STRESS SCALE (DASS-21) IN MEDICAL FACULTY STAFF SAMPLE: THE PILOT STUDY
PREDICTIVE VALUE OF PSYCHOMETRIC TESTING IN CONTEXT OF CREATING ADAPTIVE ENVIRONMENT FOR HIGHER MEDICAL EDUCATION
EVIDENCE-BASED NURSING PRACTICE. LITERATURE REVIEW
DEVELOPMENT OF AN ALGORITHM FOR DISPENSARY OBSERVATION OF PATIENTS WHO UNDERWENT CORONARY ARTERY BYPASS GRAFTING
PSYCHOEMOTIONAL STATUS IN PATIENTS WITH CHRONIC HEART FAILURE. LITERATURE REVIEW.